Literature DB >> 21143345

What factors determine the severity of hepatitis A-related acute liver failure?

V Ajmera1, G Xia, G Vaughan, J C Forbi, L M Ganova-Raeva, Y Khudyakov, C K Opio, R Taylor, R Restrepo, S Munoz, R J Fontana, W M Lee.   

Abstract

The reason(s) that hepatitis A virus (HAV) infection may progress infrequently to acute liver failure are poorly understood. We examined host and viral factors in 29 consecutive adult patients with HAV-associated acute liver failure enrolled at 10 sites participating in the US ALF Study Group. Eighteen of twenty-four acute liver failure sera were PCR positive while six had no detectable virus. HAV genotype was determined using phylogenetic analysis and the full-length genome sequences of the HAV from a cute liver failure sera were compared to those from self-limited acute HAV cases selected from the CDC database. We found that rates of nucleotide substitution did not vary significantly between the liver failure and non-liver failure cases and there was no significant variation in amino acid sequences between the two groups. Four of 18 HAV isolates were sub-genotype IB, acquired from the same study site over a 3.5-year period. Sub-genotype IB was found more frequently among acute liver failure cases compared to the non-liver failure cases (chi-square test, P < 0.01). At another centre, a mother and her son presented with HAV and liver failure within 1 month of each other. Predictors of spontaneous survival included detectable serum HAV RNA, while age, gender, HAV genotype and nucleotide substitutions were not associated with outcome. The more frequent appearance of rapid viral clearance and its association with poor outcomes in acute liver failure as well as the finding of familial cases imply a possible host genetic predisposition that contributes to a fulminant course. Recurrent cases of the rare sub-genotype IB over several years at a single centre imply a community reservoir of infection and possible increased pathogenicity of certain infrequent viral genotypes.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21143345      PMCID: PMC4931904          DOI: 10.1111/j.1365-2893.2010.01410.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  23 in total

1.  Sequence-specific, single-primer amplification and detection of PCR products for identification of hepatitis viruses.

Authors:  O V Nainan; T L Cromeans; H S Margolis
Journal:  J Virol Methods       Date:  1996-09       Impact factor: 2.014

2.  Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection.

Authors:  Kenneth L Muldrew; Laura P James; Leslie Coop; Sandra S McCullough; Howard P Hendrickson; Jack A Hinson; Philip R Mayeux
Journal:  Drug Metab Dispos       Date:  2002-04       Impact factor: 3.922

3.  Familial cluster of fulminant hepatitis A infection.

Authors:  R Y Durst; N Goldsmidt; J Namestnick; R Safadi; Y Ilan
Journal:  J Clin Gastroenterol       Date:  2001 May-Jun       Impact factor: 3.062

4.  Analysis of full-length hepatitis A virus genome in sera from patients with fulminant and self-limited acute type A hepatitis.

Authors:  K Fujiwara; O Yokosuka; K Fukai; F Imazeki; H Saisho; M Omata
Journal:  J Hepatol       Date:  2001-07       Impact factor: 25.083

Review 5.  Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.

Authors:  S Vento
Journal:  J Viral Hepat       Date:  2000-05       Impact factor: 3.728

6.  Viral hepatitis-related acute liver failure.

Authors:  Frank Vinholt Schiødt; Timothy J Davern; A Obaid Shakil; Brendan McGuire; Grace Samuel; William M Lee
Journal:  Am J Gastroenterol       Date:  2003-02       Impact factor: 10.864

Review 7.  Fulminant hepatic failure: summary of a workshop.

Authors:  J H Hoofnagle; R L Carithers; C Shapiro; N Ascher
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

8.  Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure.

Authors:  Laura P James; Lynda Letzig; Pippa M Simpson; Edmund Capparelli; Dean W Roberts; Jack A Hinson; Timothy J Davern; William M Lee
Journal:  Drug Metab Dispos       Date:  2009-05-13       Impact factor: 3.922

9.  Hepatitis A epidemic in the elderly.

Authors:  Geri R Brown; Kim Persley
Journal:  South Med J       Date:  2002-08       Impact factor: 0.954

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

View more
  14 in total

Review 1.  Liver Failure due to Acute Viral Hepatitis (A-E).

Authors:  Paul Manka; Jens Verheyen; Guido Gerken; Ali Canbay
Journal:  Visc Med       Date:  2016-04-07

2.  Time to Reconsider Hepatitis A Vaccination in Food Handlers: Are We Seeing More Outbreaks and Severe Disease?

Authors:  Hyun Sue Kim; Jordan Lydia Torres; Anthony Baffoe-Bonnie
Journal:  Open Forum Infect Dis       Date:  2022-04-12       Impact factor: 4.423

3.  Whole genome sequencing to identify host genetic risk factors for severe outcomes of hepatitis a virus infection.

Authors:  Dustin Long; Oren K Fix; Xutao Deng; Mark Seielstad; Adam S Lauring
Journal:  J Med Virol       Date:  2014-06-30       Impact factor: 2.327

4.  Epidemiological changes in hepatitis A in Korea: increasing age and its effect on clinical outcomes.

Authors:  J J Shim; S O Chin; C K Lee; J Y Jang; B H Kim
Journal:  Epidemiol Infect       Date:  2012-02-16       Impact factor: 4.434

5.  Ultra-deep sequencing analysis of the hepatitis A virus 5'-untranslated region among cases of the same outbreak from a single source.

Authors:  Shuang Wu; Shingo Nakamoto; Tatsuo Kanda; Xia Jiang; Masato Nakamura; Tatsuo Miyamura; Hiroshi Shirasawa; Nobuyuki Sugiura; Azusa Takahashi-Nakaguchi; Tohru Gonoi; Osamu Yokosuka
Journal:  Int J Med Sci       Date:  2013-12-20       Impact factor: 3.738

6.  Hepatitis A Virus: Essential Knowledge and a Novel Identify-Isolate-Inform Tool for Frontline Healthcare Providers.

Authors:  Kristi L Koenig; Siri Shastry; Michael J Burns
Journal:  West J Emerg Med       Date:  2017-10-18

7.  Inherited IL-18BP deficiency in human fulminant viral hepatitis.

Authors:  Eleftherios Michailidis; Cecilia B Korol; Emmanuelle Jouanguy; Jean-Laurent Casanova; Serkan Belkaya; Mohammad Kabbani; Aurélie Cobat; Paul Bastard; Yoon Seung Lee; Nicholas Hernandez; Scott Drutman; Ype P de Jong; Eric Vivier; Julie Bruneau; Vivien Béziat; Bertrand Boisson; Lazaro Lorenzo-Diaz; Soraya Boucherit; Mylène Sebagh; Emmanuel Jacquemin; Jean-François Emile; Laurent Abel; Charles M Rice
Journal:  J Exp Med       Date:  2019-06-18       Impact factor: 14.307

8.  Hepatitis E virus in patients with acute severe liver injury.

Authors:  Claire Louise Crossan; Kenneth J Simpson; Darren G Craig; Christopher Bellamy; Janice Davidson; Harry R Dalton; Linda Scobie
Journal:  World J Hepatol       Date:  2014-06-27

9.  Fatal acute hepatic failure in a family infected with the hepatitis A virus subgenotype IB: A case report.

Authors:  Yuichi Yoshida; Yohei Okada; Akiko Suzuki; Keisuke Kakisaka; Yasuhiro Miyamoto; Akio Miyasaka; Yasuhiro Takikawa; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

Review 10.  Human genetic basis of fulminant viral hepatitis.

Authors:  Emmanuelle Jouanguy
Journal:  Hum Genet       Date:  2020-04-13       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.